1-7 of 7
Nam H. Dang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer

Shunsuke Kondo, Satoshi Iwata, Taketo Yamada, Yusuke Inoue, Hiromi Ichihara, Yoshiko Kichikawa, Tomoki Katayose, Akiko Souta-Kuribara, Hiroto Yamazaki, Osamu Hosono, Hiroshi Kawasaki, Hirotoshi Tanaka, Yuichiro Hayashi, Michiie Sakamoto, Kazunori Kamiya, Nam H. Dang, Chikao Morimoto
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (22): 6326–6338.
https://doi.org/10.1158/1078-0432.CCR-11-2162
Published: 14 November 2012
View article titled, Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer
Open the PDF for Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer in another window
Includes: Supplementary data
Journal Articles

CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma

Keisuke Aoe, Vishwa Jeet Amatya, Nobukazu Fujimoto, Kei Ohnuma, Osamu Hosono, Akio Hiraki, Masanori Fujii, Taketo Yamada, Nam H. Dang, Yukio Takeshima, Kouki Inai, Takumi Kishimoto, Chikao Morimoto
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (5): 1447–1456.
https://doi.org/10.1158/1078-0432.CCR-11-1990
Published: 01 March 2012
View article titled, CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma
Open the PDF for CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma in another window
Includes: Supplementary data
Journal Articles

Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma

Andres Forero-Torres, Sven de Vos, Brad L. Pohlman, Maksim Pashkevich, Damien M. Cronier, Nam H. Dang, Susan P. Carpenter, Barrett W. Allan, James G. Nelson, Christopher A. Slapak, Mitchell R. Smith, Brian K. Link, James E. Wooldridge, Kristen N. Ganjoo
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (5): 1395–1403.
https://doi.org/10.1158/1078-0432.CCR-11-0850
Published: 01 March 2012
View article titled, Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma
Open the PDF for Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma in another window
Includes: Supplementary data
Journal Articles

Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma Tumors

Teruo Inamoto, Taketo Yamada, Kei Ohnuma, Shinichiro Kina, Nozomu Takahashi, Tadanori Yamochi, Sakiko Inamoto, Yoji Katsuoka, Osamu Hosono, Hirotoshi Tanaka, Nam H. Dang, Chikao Morimoto
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (14): 4191–4200.
https://doi.org/10.1158/1078-0432.CCR-07-0110
Published: 18 July 2007
View article titled, Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma Tumors
Open the PDF for Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma Tumors in another window
Journal Articles

Anti-CD26 Monoclonal Antibody–Mediated G1-S Arrest of Human Renal Clear Cell Carcinoma Caki-2 Is Associated with Retinoblastoma Substrate Dephosphorylation, Cyclin-Dependent Kinase 2 Reduction, p27kip1 Enhancement, and Disruption of Binding to the Extracellular Matrix

Teruo Inamoto, Tadanori Yamochi, Kei Ohnuma, Satoshi Iwata, Shinichiro Kina, Sakiko Inamoto, Masaaki Tachibana, Yoji Katsuoka, Nam H. Dang, Chikao Morimoto
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (11): 3470–3477.
https://doi.org/10.1158/1078-0432.CCR-06-0361
Published: 01 June 2006
View article titled, Anti-CD26 Monoclonal Antibody–Mediated G<sub>1</sub>-S Arrest of Human Renal Clear Cell Carcinoma Caki-2 Is Associated with Retinoblastoma Substrate Dephosphorylation, Cyclin-Dependent Kinase 2 Reduction, p27<sup>kip1</sup> Enhancement, and Disruption of Binding to the Extracellular Matrix
Open the PDF for Anti-CD26 Monoclonal Antibody–Mediated G<sub>1</sub>-S Arrest of Human Renal Clear Cell Carcinoma Caki-2 Is Associated with Retinoblastoma Substrate Dephosphorylation, Cyclin-Dependent Kinase 2 Reduction, p27<sup>kip1</sup> Enhancement, and Disruption of Binding to the Extracellular Matrix in another window
Journal Articles

Phase II Clinical Trial of Interleukin-12 in Patients with Relapsed and Refractory Non-Hodgkin’s Lymphoma and Hodgkin’s Disease

Anas Younes, Barbara Pro, Michael J. Robertson, Ian W. Flinn, Jorge E. Romaguera, Fredrick Hagemeister, Nam H. Dang, Paolo Fiumara, Evelyne M. Loyer, Fernando F. Cabanillas, Peter W. McLaughlin, Maria Alma Rodriguez, Felipe Samaniego
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5432–5438.
https://doi.org/10.1158/1078-0432.CCR-04-0540
Published: 24 August 2004
View article titled, Phase II Clinical Trial of Interleukin-12 in Patients with Relapsed and Refractory Non-Hodgkin’s Lymphoma and Hodgkin’s Disease
Open the PDF for Phase II Clinical Trial of Interleukin-12 in Patients with Relapsed and Refractory Non-Hodgkin’s Lymphoma and Hodgkin’s Disease in another window
Journal Articles

In Vitro and in Vivo Antitumor Effect of the Anti-CD26 Monoclonal Antibody 1F7 on Human CD30+ Anaplastic Large Cell T-Cell Lymphoma Karpas 299

Linus Ho, Ugur Aytac, L. Clifton Stephens, Kei Ohnuma, Gordon B. Mills, Kathryn S. McKee, Christopher Neumann, Ruth LaPushin, Fernando Cabanillas, James L. Abbruzzese, Chikao Morimoto, Nam H. Dang
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (7): 2031–2040.
Published: 01 July 2001
View article titled, <em>In Vitro</em> and <em>in Vivo</em> Antitumor Effect of the Anti-CD26 Monoclonal Antibody 1F7 on Human CD30+ Anaplastic Large Cell T-Cell Lymphoma Karpas 299
Open the PDF for <em>In Vitro</em> and <em>in Vivo</em> Antitumor Effect of the Anti-CD26 Monoclonal Antibody 1F7 on Human CD30+ Anaplastic Large Cell T-Cell Lymphoma Karpas 299 in another window